Global Sustained Release Excipients Market
Pharmaceuticals

Understand How The Sustained Release Excipients Market Is Poised To Grow Through 2023-2032

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global sustained release excipients market is on the brink of significant growth, with a projected increase from $1.18 billion in 2022 to $1.29 billion in 2023 at a robust Compound Annual Growth Rate (CAGR) of 9.8%. The trajectory continues, aiming at a market size of $1.80 billion by 2027, fueled by an 8.6% CAGR.

  1. Driving Forces: The Prevalence of Chronic and Acute Diseases
  • Chronic and acute diseases, distinct in their duration and severity, are pivotal factors in propelling market growth.
  • Sustained-release excipients play a crucial role in formulating pharmaceuticals for both chronic and acute conditions.
  • The World Health Organization (WHO) reports that cardiovascular diseases alone account for 17.9 million annual deaths, emphasizing the need for effective drug delivery systems.
  • The Pan American Health Organization notes a 4.5% increase in tuberculosis cases in 2021, further underlining the importance of sustained-release solutions.
  1. Industry Giants: Key Players in the Market

Major players shaping the sustained release excipients market landscape include:

  • Mylan N.V.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Novartis AG
  • Ashland Global Holdings
  • BASF Corporation
  • Croda International PLC
  • GlaxoSmithKline PLC
  • Evonik Industries
  • Gattefosse SAS
  • International Flavors And Fragrances Inc.
  • Merck KGaA
  • AstraZeneca PLC
  • Colorcon Inc.
  • Salix Pharmaceuticals Inc.
  1. Innovation: The Key Trend in Sustained Release Excipients
  • Product innovation emerges as a crucial trend, driving market competitiveness.
  • Nutriventia Limited, an India-based pharmaceutical company, exemplifies this trend with the launch of Prolanza.
  • Prolanza, a sustained-release ashwagandha ingredient, offers continuous stress-reduction support with unique release mechanisms.
  • Its sustained-release profile ensures prolonged therapeutic effects, surpassing traditional components in absorption and bioavailability.
  • The product’s focus on adaptability and stress reduction aligns with contemporary health needs, contributing to its potential success.
  1. Market Segmentation: Understanding the Landscape

The global sustained release excipients market is segmented based on:

  1. Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan
  2. Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
  3. Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation
  1. Regional Dynamics: North America Leading, Asia-Pacific Surging Ahead
  • In 2022, North America emerged as the largest region in the global sustained release excipients market.
  • Asia-Pacific is anticipated to experience the fastest growth in the forecast period, reflecting evolving healthcare needs and increasing pharmaceutical activities.

View More On The Sustained Release Excipients Market Report 2023 – https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

Request A Sample Of The Global Sustained Release Excipients Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=10822&type=smp

The Sustained Release Excipients Global Market Report 2023  provides an in-depth analysis on the sustained release excipients market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the sustained release excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Pharmaceutical Excipients Global Market Report 2023
Nuclear Medicine Global Market Report 2023
Precision Medicine Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model